InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,234.00
(
-0.13%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
-0.72%
)
Bitcoin
64,134.12
(
-1.06%
)
Post# of 320
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Getac1ue2

Send PM Follow Ignore
Followers 0
Posts 43
Boards Moderated 0
Alias Born 06/16/2010

Getac1ue2

Re: None

Thursday, 08/05/2010 7:05:23 PM

Thursday, August 05, 2010 7:05:23 PM

Post# of 320
TAMPA, Fla. & MINNEAPOLIS, Aug 05, 2010 (BUSINESS WIRE) -- Biovest
International, Inc. (OTCQB: "BVTI"), a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company has retained the investment banking firm, ROTH Capital Partners, LLC (ROTH). ROTH has been engaged to assist Biovest in raising capital
as the Company prepares to emerge from Chapter 11 reorganization.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up